Sunday, November 25, 2018

Smoking is associated with increased disease activity during natalizumab (Tysabri) treatment in multiple sclerosis.

Published by Aaron Boster, MD

In this video, I review an MS research abstract with you. If you're curious about scientific literature in Multiple Sclerosis, this video is for you. MS Research 2018: Smoking While On Tysabri Link to Article Abstract: Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis. --- PubMed - NCBI
-----------------------------------------------------------------------------------------------------------


::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

To receive MS news and information via e-mail, Please Click here 

CLICK BOX to SUBSCRIBE to our MS Learning Channel on YouTube: 

                      
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

No comments:

Post a Comment

Thank You for leaving a comment.
Attempts to redirect viewers of this blog to another website and / or any marketing, will be removed.

Note: Only a member of this blog may post a comment.